|
⚲
|
| Keyboard |
| Cheng Liu | |
|---|---|
| Firm | |
| Address | 5858 Horton Street, Suite 370 Emeryville, CA 94608 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Eureka Therapeutics Inc | 021-481903 | Executive Officer | of 20.0 M |
||
| Invisishield Technologies Ltd | 021-460400 | Executive Officer | 2.5 M of 2.5 M |
||
| Invisimask Technologies Ltd | 021-437231 | Executive Officer | 0.9 M of 1.0 M |
||
| JW Cayman Therapeutics Co Ltd | 021-371020 | Director | 105.5 M of 105.5 M |
||
| Eureka Therapeutics Inc | 021-358835 | Executive Officer | 45.0 M of 45.0 M |
||
| Eureka Therapeutics Inc | 021-314816 | Executive Officer | 20.0 M of 20.0 M |
||
| Eureka Therapeutics Inc | 021-276040 | Executive Officer | 26.6 M of 60.0 M |
||
| Eureka Therapeutics Inc | 021-225088 | Executive Officer | 21.0 M of 21.0 M |
||
| China Special Opportunities Fund III LP | 021-152871 | Executive Officer | 260.0 M of 260.0 M |
||
| Forebright Capital Management Limited | |||||
| Forebright New Opportunities Fund LP | 021-222202 | Executive Officer | 236.8 M of 600.0 M |
435.5 M | |